HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Stefoni Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

2/2012A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
8/2010FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma.
9/2002Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.
6/2002Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation.
9/2001MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results.
3/2001Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Stefoni Research Topics

Disease

6Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2012 - 03/2001
4Hodgkin Disease (Hodgkin's Disease)
12/2019 - 07/2000
4Lymphoma (Lymphomas)
06/2002 - 02/2000
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2024 - 04/2010
2Neutropenia
12/2019 - 04/2008
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2016 - 04/2008
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2012 - 08/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2016
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
06/2010
1Mycosis Fungoides
04/2010
1T-Cell Lymphoma (Lymphoma, T Cell)
04/2010
1Thrombocytopenia (Thrombopenia)
04/2008
1Sclerosis
02/2001
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2001
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2000
1Neoplasms (Cancer)
09/2000
1Hairy Cell Leukemia
09/2000
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2000

Drug/Important Bio-Agent (IBA)

4fludarabineIBA
02/2012 - 02/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2016 - 09/2002
3Vincristine (Oncovin)FDA LinkGeneric
01/2016 - 09/2002
3Mitoxantrone (Novantrone)FDA LinkGeneric
02/2012 - 03/2000
3ibritumomab tiuxetan (Zevalin)FDA Link
02/2012 - 04/2008
3Prednisone (Sone)FDA LinkGeneric
04/2008 - 03/2001
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 04/2008
2Rituximab (Mabthera)FDA Link
01/2016 - 02/2012
2GemcitabineFDA Link
04/2010 - 09/2000
1Biomarkers (Surrogate Marker)IBA
01/2024
1Cell-Free Nucleic AcidsIBA
01/2024
1Brentuximab VedotinIBA
12/2019
1Bendamustine HydrochlorideFDA Link
12/2019
1Prednisolone (Predate)FDA LinkGeneric
01/2016
1YttriumIBA
04/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2002
1Bleomycin (Blenoxane)FDA LinkGeneric
09/2002
1Etoposide (VP 16)FDA LinkGeneric
09/2002
1Fluorine-18IBA
06/2002
1GalliumIBA
11/2001
1Vinorelbine (Navelbine)FDA LinkGeneric
03/2001
1Epirubicin (Ellence)FDA LinkGeneric
03/2001
1CladribineFDA LinkGeneric
09/2000
1pyrimidineIBA
09/2000
1AntimetabolitesIBA
09/2000
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
02/2000

Therapy/Procedure

7Drug Therapy (Chemotherapy)
04/2010 - 07/2000
4Radioimmunotherapy
01/2016 - 04/2008
3Radiotherapy
06/2002 - 02/2001
2Salvage Therapy
12/2019 - 11/2000
2MACOP-B regimen
06/2010 - 09/2001
1Therapeutics
12/2019
1Stem Cell Transplantation
12/2019
1Aftercare (After-Treatment)
08/2010
1Combination Drug Therapy (Combination Chemotherapy)
04/2008
1FLU-ID regimen
02/2000